Press release
Malaria Treatment Market to Perceive Substantial Growth During 2025
A recent market research report by Transparency Market Research delves deep into the past and present growth dynamics of the global market for malaria treatment, a market that has witnessed vast focus on R&D activities and the active participation of governments and non-government organizations through grants and funds in the past years. The report is titled “Malaria Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017–2025.”Read Report Overview @ https://www.transparencymarketresearch.com/malaria-treatment-market.html
According to the report, the vast funds ploughed by government bodies into activities aimed at the prevention of the disease, which has remained one of the leading causes of death in a number of emerging and less-developed economies over the years, is a leading factor driving the market. According to WHO estimates, funds nearing US$2.9 bn were devoted across the globe for the treatment and eradication of malaria in 2015. In the same year, nearly 212 mn cases of the condition were reported globally and around 429,000 deaths registered. This high burden of the condition is also a key factor driving the global malaria treatment market.
For providing a more thorough account of the growth prospects of the market, the report segments it on the basis of criteria such as route of administration, treatment type, end-user, and geography. Based on the type of treatment, the market has been segmented into indicators, diagnostics tests, anti-malarial agents, and vaccines. On the basis of end-user, the market has been examined for specialty clinics, hospitals, and others. Based on the route of administration, the market has been examined for parenteral, oral, and intravenous.
Obtain the Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=41990
Geographically, the market has been examined for regions such as North America, Middle East and Africa, Latin America, Asia Pacific, and Europe. The prevalence of malaria in regions such as Middle East and Africa and Asia Pacific is significantly higher as compared to Europe and North America. It is thus justified that the malaria treatment market acquires a large share of its revenue from sales across these regions. According to the WHO, nearly 53% of the population in the Middle East and Africa region is at the risk of malaria. Moreover, nearly 76% of all the malaria cases registered in 2015 were only from 13 countries across the globe, majority of which were from these regions.
The report also includes a thorough assessment of the vendor landscape of the global malaria treatment market. The report provides an overview of the leading companies in present times, recent developments, and the strategies adopted by companies to find a better treatment method for the deadly viral. Some of the leading companies operating in the global malaria treatment market are Concordia International Corp., Novartis AG, Mylan Pharmaceuticals Inc., Pfizer, Inc., Teva Pharmaceuticals, Inc., Amyris, Roxane Laboratories, Inc., GlaxoSmithKline, Lannett Company, Inc., Baxter International Inc., Fresenius Kabi, LLC, and Sanofi.
Request for Report TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=41990
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Malaria Treatment Market to Perceive Substantial Growth During 2025 here
News-ID: 1185862 • Views: …
More Releases from Transparency Market Research
Functional Coffee Market Expanding at 7.6% CAGR Through 2035 - By Product Type / …
The global functional coffee market was valued at US$ 21.5 Bn in 2024 and is projected to reach US$ 48.1 Bn by 2035, expanding at a compound annual growth rate (CAGR) of 7.6% from 2025 to 2035. This steady growth trajectory reflects the strong convergence of coffee consumption habits with rising demand for functional and wellness-oriented beverages. Functional coffee has transitioned from a niche category to a mainstream product offering,…
Global Electric Face Cleanser Market Poised for Robust Growth, projected to Reac …
The global electric face cleanser market is witnessing a transformative growth phase as consumers increasingly integrate advanced skincare technologies into their daily routines. Valued at USD 9.8 billion in 2025, the market is projected to expand significantly and reach USD 23.6 billion by 2036, growing at a healthy compound annual growth rate (CAGR) of 8.6% from 2026 to 2036. This growth trajectory underscores the rising importance of personal care technology,…
Asthma and COPD Drugs Market to Reach US$ 82.2 Billion by 2036, Growing at 5.7% …
The global asthma and COPD drugs market demonstrated strong fundamentals in 2025, with a valuation of US$ 44.7 Bn, reflecting the essential and recurring nature of respiratory therapeutics. Supported by a growing patient base and continuous pharmaceutical innovation, the market is projected to reach US$ 82.2 Bn by 2036, expanding at a compound annual growth rate (CAGR) of 5.7% from 2026 to 2036.
This growth trajectory highlights the increasing reliance on…
Low-Alcohol Beverages Market Outlook 2035: Global Industry Set to Expand from US …
The global low-alcohol beverages market is undergoing a structural transformation as consumers increasingly prioritize health, moderation, and mindful drinking without sacrificing taste or social experiences. Valued at US$ 2.1 billion in 2024, the market is projected to reach US$ 4.6 billion by 2035, expanding at a healthy CAGR of 7.5% from 2025 to 2035. This sustained growth reflects changing lifestyle preferences, generational shifts in alcohol consumption, and continuous innovation by…
More Releases for Malaria
Industry Dynamics of Cerebral Malaria Therapeutics
Global Cerebral Malaria Therapeutics Market: Overview
Cerebral malaria, a severe neuropathological complication, primarily caused by Plasmodium falciparum. The infectious disease has become prevalent in tropical and sub-tropical countries. The cerebral malaria therapeutics market has evolved on the back of increased understanding of pathogenesis of the neurological syndrome. A growing array of biomarkers and tool in recent years have helped underpin the growing revenue potential in the market, giving rise to numerous…
Malaria Vaccines – Paving the Way for a Malaria-free World
Recent Study on “Malaria Vaccines Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis and Forecast, 2018-2026” Added to Coherent Market Insights Reports Database.
Malaria Vaccines Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Malaria Vaccines market research report is a professional…
Malaria Disease Drug Pipeline Analysis
“Malaria Disease Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Malaria. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each drug…
Rising Prevalence of Cerebral Malaria and Increasing Novel Drug Treatment Drives …
Malaria is a mosquito-borne infectious disease affecting humans and animals caused by parasitic protozoan belonging to the plasmodium family. Malaria is typically transmitted from human to human through the bite of an infected Anopheles (female) mosquito. Symptoms of malaria include fever, headache, fatigue, muscle pain, diarrhea, anemia, and vomiting. Severe malaria can cause yellow skin, seizures, coma, or death. Cerebral malaria is a form of severe malaria. Cerebral malaria has…
Rising Prevalence of Cerebral Malaria and Increasing Novel Drug Treatment Drives …
Malaria is a mosquito-borne infectious disease affecting humans and animals caused by parasitic protozoan belonging to the plasmodium family. Malaria is typically transmitted from human to human through the bite of an infected Anopheles (female) mosquito. Symptoms of malaria include fever, headache, fatigue, muscle pain, diarrhea, anemia, and vomiting. Severe malaria can cause yellow skin, seizures, coma, or death. Cerebral malaria is a form of severe malaria. Cerebral malaria has…
Malaria Diagnostics Market : Future Growth Potential Of The Malaria Diagnostic & …
Malaria is caused by the Plasmodium parasite, which is transmitted by the female Anopheles mosquito. As per the WHO, there were around 203 mn cases of malaria worldwide in 2012, resulting in approximately 627,000 deaths. The diagnosis of malaria involves detection with the help of blood tests and microscopy. Early and accurate diagnosis of malaria is vital for the rapid recovery of the patient and this has raised investments in…
